Koronis Biomedical Technologies Corporation (KBT) proposes the development of a chronic disease management solution. According to the NIH, chronic diseases in 2005 will account for 75% of U.S. healthcare costs. The proposed solution will serve the large population of patients suffering from one or more of four chronic illnesses: diabetes, congestive heart failure, chronic obstructive pulmonary disease, or asthma. These diseases represent 80% of the patients with chronic disease. KBT proposes a teaming relationship with a pioneering healthcare technology company in the business of providing a modern, interactive collaboration between those patients who are self-monitoring a chronic condition and the health professionals that care for them. The proposed project will integrate the developed technology into a commercially available disease management platform to create a new chronic disease management solution that has a high probability of commercial success. ? ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44AG025582-02
Application #
7106738
Study Section
Special Emphasis Panel (ZRG1-HOP-E (10))
Program Officer
Stahl, Sidney M
Project Start
2005-04-01
Project End
2008-05-31
Budget Start
2006-09-01
Budget End
2007-05-31
Support Year
2
Fiscal Year
2006
Total Cost
$422,895
Indirect Cost
Name
Koronis Biomedical Technologies Corporat
Department
Type
DUNS #
140696332
City
Maple Grove
State
MN
Country
United States
Zip Code
55369